The markets closed higher with the Dow rising 23 points to 22,405 on the last trading day of the third quarter. Nasdaq climbed 42 points to 6,495.
On the upside
Roth Capital Partners analyst Brian Alger reiterated his Buy rating on Veritone (Nasdaq: VERI) and lifted his price target from $13 to $62.
SMART Global Holdings (Nasdaq: SGH) reported sharply higher fourth quarter earnings.
The Food and Drug Administration Advisory Committee said that PTC Therapeutics' (Nasdaq: PTCT) Duchenne muscular dystrophy treatment needed more testing but did not reject the drug.
On the downside
Profit taking continued to weigh down shares of Zynerba Pharmaceuticals (Nasdaq: ZYNE).
Citi downgraded LSC Communications (NYSE: LKSD) from a Neutral rating a Sell rating and lowered its price target from $18.00 to $14.00.
Shares of SCANA (NYSE: SCG) fell again.
In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 2 on the NYSE and by more than 4 to 3 on Nasdaq. The broader S&P 500 gained 9 points to 2,519. Bitcoin lost $6 to $4,180.
